SARS-CoV-2 anti-S1 and anti-N GMCs approximately one year after the start of the Dutch SARS-CoV-2 epidemic were associated with the number of immune events and overall infection severity when an infection took place, but not with having had or having long COVID or long-term loss of smell/taste. This evidence concerns the gene PSMD1 and infection.